Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oncobiologics Inc (NASDAQ:ONS)

1.16
Delayed Data
As of 3:57pm ET
 +0.01 / +0.87%
Today’s Change
0.78
Today|||52-Week Range
3.95
-10.77%
Year-to-Date
No recent news for Oncobiologics Inc.

Today’s Trading

Previous close1.15
Today’s open1.16
Day’s range1.15 - 1.18
Volume16,153
Average volume (3 months)125,488
Market cap$28.7M
Data as of 3:57pm ET, 01/23/2018

Growth & Valuation

Earnings growth (last year)+50.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+27.92%
P/E ratioNM
Price/Sales8.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...-0.01-0.13%
BNTCBenitec Biopharma Lt...-0.13-3.70%
----
DRIODarioHealth Corp-0.05-2.99%
Data as of 4:00pm ET, 01/23/2018

Financials

Last reporting dateAugust 30, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$3.8M
Annual profit (last year)-$40.0M
Net profit margin-1,050.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Pankaj Mohan
CFO, Secretary &
Principal Accounting Officer
Lawrence A. Kenyon
Corporate headquarters
Cranbury, New Jersey

Forecasts